Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG: 2196)

Shanghai Fosun Pharmaceutical (Group) Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	67,285	67,854	98,266	139,764	149,388	72,809
Market Cap Growth	-2.59%	-30.95%	-29.69%	-6.44%	105.18%	10.35%
Enterprise Value	100,656	98,300	124,479	165,708	175,428	97,214
Last Close Price	14.00	16.61	23.89	32.15	34.36	21.52
PE Ratio	-	25.81	23.30	24.08	34.34	19.59
PS Ratio	1.59	1.49	1.98	2.92	4.15	2.28
PB Ratio	1.12	1.09	1.61	2.35	2.74	1.66
P/TBV Ratio	2.82	2.88	3.99	5.83	6.40	4.35
P/OCF Ratio	16.80	18.04	20.61	28.91	48.76	20.20
EV/Sales Ratio	2.25	2.16	2.51	3.46	4.87	3.04
EV/EBITDA Ratio	16.37	23.25	19.87	32.27	36.18	23.64
EV/EBIT Ratio	39.03	75.34	32.19	53.22	56.42	36.52
EV/FCF Ratio	-439.13	-	-	-	-	-
Debt / Equity Ratio	0.59	0.62	0.56	0.53	0.52	0.56
Debt / EBITDA Ratio	6.08	8.54	5.25	5.86	5.63	5.74
Asset Turnover	0.37	0.38	0.44	0.44	0.38	0.39
Inventory Turnover	2.84	3.01	3.76	3.82	3.03	3.20
Quick Ratio	0.68	0.73	0.78	0.75	0.71	0.89
Current Ratio	0.92	1.00	1.06	1.04	1.01	1.17
Return on Equity (ROE)	4.79%	5.23%	7.70%	10.55%	9.25%	10.28%
Return on Assets (ROA)	1.33%	0.67%	2.13%	1.79%	2.05%	2.03%
Return on Capital (ROIC)	1.64%	0.84%	2.70%	2.21%	2.50%	2.52%
Earnings Yield	3.19%	3.87%	4.29%	4.15%	2.91%	5.10%
FCF Yield	-0.31%	-3.12%	-1.92%	-0.91%	-1.48%	-1.14%
Dividend Yield	1.92%	1.79%	1.99%	2.14%	1.49%	2.03%
Payout Ratio	97.52%	102.89%	63.64%	40.48%	50.09%	56.13%
Buyback Yield / Dilution	-0.42%	-2.40%	-1.74%	-	-	-1.57%
Total Shareholder Return	-0.42%	-0.61%	0.25%	2.14%	1.49%	0.45%

Source: S&P Capital IQ. Standard template. Financial Sources.